Showing 401 - 420 results of 2,945 for search '"hepatitis"', query time: 0.05s Refine Results
  1. 401

    Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis by Dong Wu, Shu-Mei Wu, Jie Lu, Ying-Qun Zhou, Ling Xu, Chuan-Yong Guo

    Published 2013-01-01
    “…Many studies have found that the antibiotic rifaximin is effective for the treatment of hepatic encephalopathy. However, there is no uniform view on the efficacy and safety of rifaximin. …”
    Get full text
    Article
  2. 402

    Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling by Weidong Shao, Hui Xu, Kanghua Zeng, Mingzhou Ye, Renjun Pei, Kai Wang

    Published 2025-01-01
    “…The liver organoids also serve as ideal platforms for studying liver diseases such as hepatitis, liver fibrosis, viral liver diseases, and monogenic diseases. …”
    Get full text
    Article
  3. 403
  4. 404
  5. 405
  6. 406

    Complementary and Alternative Medicine Use by Patients Chronically Infected with Hepatitis C Virus by Colin P White, Gerilynn Hirsch, Sunil Patel, Fatin Adams, Kevork M Peltekian

    Published 2007-01-01
    “…The extent of use of CAM in chronic hepatitis C virus (HCV) infected patients was determined, and the demographic and clinical data between users and nonusers of CAM was compared.…”
    Get full text
    Article
  7. 407

    Identification of Novel Clinical Factors Associated with Hepatic Fat Accumulation in Extreme Obesity by Glenn S. Gerhard, Peter Benotti, G. Craig Wood, Xin Chu, George Argyropoulos, Anthony Petrick, William E. Strodel, Jon D. Gabrielsen, Anna Ibele, Christopher D. Still, Christopher Kingsley, Johanna DiStefano

    Published 2014-01-01
    “…A limited set of clinical factors can be used to model hepatic fat accumulation with moderate accuracy and may provide potential mechanistic insights in the setting of extreme obesity.…”
    Get full text
    Article
  8. 408

    The Transmission Dynamics of Hepatitis B Virus via the Fractional-Order Epidemiological Model by Tahir Khan, Zi-Shan Qian, Roman Ullah, Basem Al Alwan, Gul Zaman, Qasem M. Al-Mdallal, Youssef El Khatib, Khaled Kheder

    Published 2021-01-01
    “…We investigate and analyze the dynamics of hepatitis B with various infection phases and multiple routes of transmission. …”
    Get full text
    Article
  9. 409

    Molecular Mechanisms of Phthalate-Induced Hepatic Injury and Amelioration by Plant-Based Principles by Lalit Kumar Singh, Rashmi Pandey, Nikhat Jamal Siddiqi, Bechan Sharma

    Published 2025-01-01
    “…The physicochemical properties of phthalates indicate their lipophilicity, environmental persistence, and bioaccumulation potential, influencing their absorption, distribution, and hepatic biotransformation. The prolonged exposure to phthalates adversely influences the biological redox system by altering the levels of the enzymatic and non-enzymatic antioxidants, molecular signaling pathways, and causing hepatic pathogenesis. …”
    Get full text
    Article
  10. 410

    Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis by Wenchang Yang, Yaxin Wang, Peng Zhang, Tao Wang, Chengguo Li, Xin Tong, Xiangyu Zeng, Yuping Yin, Kaixiong Tao, Ruidong Li

    Published 2022-01-01
    “…However, its function in autoimmune hepatitis- (AIH-) associated hepatic injury has not been investigated. …”
    Get full text
    Article
  11. 411

    Hepatic Cholesterol-25-Hydroxylase Overexpression Improves Systemic Insulin Sensitivity in Mice by Britta Noebauer, Alexander Jais, Jelena Todoric, Klaus Gossens, Hedwig Sutterlüty-Fall, Elisa Einwallner

    Published 2017-01-01
    “…Our data suggest that low hepatic Ch25h levels could be considered a risk marker for unhealthy obesity.…”
    Get full text
    Article
  12. 412

    Isoniazid and Rifampicin Produce Hepatic Fibrosis through an Oxidative Stress-Dependent Mechanism by Ayan Biswas, Suman Santra, Debasree Bishnu, Gopal Krishna Dhali, Abhijit Chowdhury, Amal Santra

    Published 2020-01-01
    “…Background & Aims. Chronic hepatitis (CH) has emerged as a distinct outcome of drug-induced liver injury (DILI). …”
    Get full text
    Article
  13. 413

    Serological Evidence of Hepatitis E Virus Infection in an Indigenous North American Population by GY Minuk, A Sun, DF Sun, J Uhanova, LE Nicolle, B Larke, A Giulivi

    Published 2007-01-01
    “…BACKGROUND: Hepatitis E virus (HEV) infections are thought to be uncommon in North America. …”
    Get full text
    Article
  14. 414

    Pathological Features of Mitochondrial Ultrastructure Predict Susceptibility to Post-TIPS Hepatic Encephalopathy by Hong-bin Li, Zhen-dong Yue, Hong-wei Zhao, Lei Wang, Zhen-hua Fan, Fu-liang He, Xiao-qun Dong, Fu-quan Liu

    Published 2018-01-01
    “…Background. Post-TIPS hepatic encephalopathy (PSE) is a complex process involving numerous risk factors; the root cause is unclear, but an elevation of blood ammonia due to portosystemic shunt and metabolic disorders in hepatocytes has been proposed as an important risk factor. …”
    Get full text
    Article
  15. 415
  16. 416

    Ciliated Hepatic Foregut Cyst: Two Case Reports in Children and Review of the Literature by Maliheh Khoddami, Maryam Kazemi Aghdam, Azadeh Alvandimanesh

    Published 2013-01-01
    “…Ciliated hepatic foregut cyst (CHFC) is a rare lesion which originates from detached hepatic diverticulum or from detachment and migration of buds from the esophageal and bronchial regions of the foregut which subsequently get entrapped by the liver during the early embryonic development of the foregut. …”
    Get full text
    Article
  17. 417
  18. 418

    Amanita bisporigera-Induced Hepatic Failure: A Fatal Case of Mushroom Ingestion by Anthony Nici, Sang Kim

    Published 2011-01-01
    “…If not aggressively treated, fulminant hepatic failure may develop within several days of ingestion. …”
    Get full text
    Article
  19. 419

    Aberrant Hepatic Methionine Metabolism and Gene Methylation in the Pathogenesis and Treatment of Alcoholic Steatohepatitis by Charles H. Halsted, Valentina Medici

    Published 2012-01-01
    “…The present paper describes the effects of ethanol on the hepatic methionine cycle, followed by evidence for the central role of reduced SAM in the pathogenesis of ASH according to clinical data and experiments in ethanol-fed animals and in cell models. …”
    Get full text
    Article
  20. 420

    Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention by Shuai-Wen Huang, Hong Long, Jia-Quan Huang

    Published 2024-12-01
    “…Due to the lack of agents that directly target covalently closed circular DNA and integrated HBV DNA in hepatocytes, achieving a complete cure for chronic hepatitis B (CHB) remains challenging. The latest guidelines recommend (hepatitis B surface antigen) HBsAg loss as the ideal treatment target for improving liver function, histopathology, and long-term prognosis. …”
    Get full text
    Article